91 related articles for article (PubMed ID: 15202848)
21. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
22. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
[TBL] [Abstract][Full Text] [Related]
23. S-1 induces meibomian gland dysfunction.
Matsumoto Y; Dogru M; Sato EA; Ibrahim OM; Tatematsu Y; Ogawa Y; Tsubota K
Ophthalmology; 2010 Jun; 117(6):1275.e4-7. PubMed ID: 20522337
[No Abstract] [Full Text] [Related]
24. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
[No Abstract] [Full Text] [Related]
25. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
Sun CC; Hsu SC
Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
[No Abstract] [Full Text] [Related]
26. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
27. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
28. The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video).
Ota K; Takeuchi T; Kodama K; Ozaki H; Harada S; Kojima Y; Nouda S; Goto M; Higuchi K
Intern Med; 2018 Feb; 57(3):343-344. PubMed ID: 29093427
[TBL] [Abstract][Full Text] [Related]
29. [Risk associated with severe hematological toxicity in patients with advanced or recurrent colonic cancer receiving combination chemotherapy of S-1 and irinotecan hydrochloride].
Sunaga T; Suzuki S; Harada N; Hayashi T; Suzuki M
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2137-41. PubMed ID: 21084813
[TBL] [Abstract][Full Text] [Related]
30. [Severe bone marrow suppression during adjuvant chemotherapy for gastric cancer by S-1 and its possible relationship to dihydropyrimidine dehydrogenase deficiency].
Aragane H; Suchi K; Shimomura M; Katano T; Yasui H; Kan K
Gan To Kagaku Ryoho; 2010 Jan; 37(1):131-3. PubMed ID: 20087047
[TBL] [Abstract][Full Text] [Related]
31. Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients.
Aoyama T; Katayama Y; Murakawa M; Atsumi Y; Yamaoku K; Kanazawa A; Higuchi A; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yamamoto N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1115-20. PubMed ID: 25821166
[TBL] [Abstract][Full Text] [Related]
32. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].
Kase S
Nihon Rinsho; 2015 Feb; 73 Suppl 2():490-3. PubMed ID: 25831809
[No Abstract] [Full Text] [Related]
33. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
34. Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative.
Ohara S; Hayashi R; Hata S; Itoh N; Hanyu N; Yamamoto K
Acta Neuropathol; 1998 Nov; 96(5):527-31. PubMed ID: 9829818
[TBL] [Abstract][Full Text] [Related]
35. Toxic epidermal necrolysis associated with TS-1 in a patient with gastric cancer.
Tan CS; Lim R; Lim TC; Aw CW; Yeo SW; Lee SC
Jpn J Clin Oncol; 2011 May; 41(5):666-8. PubMed ID: 21415005
[TBL] [Abstract][Full Text] [Related]
36. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
Seishima M; Izumi T; Kanoh H
Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
[TBL] [Abstract][Full Text] [Related]
37. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer.
Kawahara H; Watanabe K; Ushigome T; Noaki R; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012; 59(113):134-7. PubMed ID: 22251528
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors.
Yeo W; Lam KO; Law AL; Lee CC; Chiang CL; Au KH; Mo FK; So TH; Lam KC; Ng WT; Li L
Hong Kong Med J; 2017 Feb; 23(1):54-62. PubMed ID: 27966431
[TBL] [Abstract][Full Text] [Related]
39. [Pulmonary veno-occlusive disease developed in a man given long-term treatment with anticancerous agents].
Maemondo M; Ebina A; Saitou K
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):823-8. PubMed ID: 9866989
[TBL] [Abstract][Full Text] [Related]
40. [Adjuvant therapy of colonic carcinoma--soon in tablet form].
Krankenpfl J; 2004; 42(5-6):157. PubMed ID: 15527221
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
